What is the dosing range for diltiazem (calcium channel blocker) infusion in rapid atrial fibrillation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diltiazem Infusion Dosing for Rapid Atrial Fibrillation

For rapid atrial fibrillation, diltiazem infusion should be initiated with a bolus dose of 0.25 mg/kg (15-20 mg) IV over 2 minutes, followed by a continuous infusion of 5-15 mg/hour, which can be maintained for up to 24 hours. 1, 2

Initial Bolus Dosing

  • Initial bolus: 0.25 mg/kg (15-20 mg) IV over 2 minutes
  • If inadequate response after 15 minutes: Second bolus of 0.35 mg/kg (20-25 mg) IV over 2 minutes 1, 2
  • Lower initial dose of 0.15 mg/kg may be considered in patients at risk for hypotension 2, 3

Continuous Infusion Protocol

  1. Start at 5-10 mg/hour immediately following bolus administration
  2. Titrate in 5 mg/hour increments as needed for heart rate control
  3. Maximum recommended infusion rate: 15 mg/hour 1, 2
  4. Maximum duration: 24 hours (longer durations have not been studied) 2

Monitoring During Infusion

  • Target heart rate: <100 beats/min or ≥20% reduction from baseline 4
  • Blood pressure: Monitor for hypotension (more common with higher doses) 3
  • Continuous cardiac monitoring is essential 5
  • Assess for signs of heart failure exacerbation 1

Pharmacokinetics and Dose Considerations

  • Elimination half-life: 6.8-6.9 hours 6
  • Diltiazem shows dose-dependent, non-linear pharmacokinetics 2, 6
  • Pharmacodynamic studies show strong correlation between plasma concentration and heart rate reduction 6

Important Cautions and Contraindications

  • Avoid in patients with:
    • Decompensated heart failure 1
    • Pre-excited atrial fibrillation (Wolff-Parkinson-White syndrome) 1
    • Severe hypotension
  • Consider lower doses (≤0.2 mg/kg) in elderly patients or those at risk for hypotension, as efficacy remains similar with fewer adverse effects 3

Transition to Oral Therapy

  • After achieving rate control with IV diltiazem, transition to oral therapy
  • Oral diltiazem can maintain rate control in approximately 77% of patients 7
  • Typical oral maintenance dose: 120-360 mg daily (extended release) 1

Remember that diltiazem infusion is effective for rate control but does not convert atrial fibrillation to normal sinus rhythm in most patients. The primary goal is to achieve adequate ventricular rate control while maintaining hemodynamic stability.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.